Capecitabine and temozolomide for metastatic intermediate to high-grade pancreatic neuroendocrine neoplasm: a single center experience

Capecitabine and temozolomide for metastatic intermediate to high-grade pancreatic neuroendocrine neoplasm: a single center experience

Background/Aims The combination of capecitabine and temozolomide (CAPTEM) is one of the treatment options for metastatic pancreatic neuroendocrine neoplasms (pNENs). This study aims to evaluate the efficacy of CAPTEM in patients with metastatic intermediate to high-grade pancreatic neuroendocrine tu...

Full description

Bibliographic Details
Main Authors: Sathathone Douangprachanh, Hyun Jin Joo, Hyeong Min Park, Nayoung Han, Hye Young Jang, Young Hwan Koh, Tae Hyun Kim, Sung-Sik Han, Sang-Jae Park, Woo Jin Lee, Sang Myung Woo, Jung Won Chun
Format: Article
Language:English
Published: The Korean Association of Internal Medicine 2022-11-01
Series:The Korean Journal of Internal Medicine
Subjects:
pancreatic neoplasms
neuroendocrine tumors
antineoplastic agents
Online Access:http://kjim.org/upload/pdf/kjim-2022-100.pdf

Internet

http://kjim.org/upload/pdf/kjim-2022-100.pdf

Similar Items